These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20936622)

  • 1. Thalidomide derivatives for the treatment of neuroinflammation.
    Contino-Pépin C; Parat A; Patinote C; Roscoe WA; Karlik SJ; Pucci B
    ChemMedChem; 2010 Dec; 5(12):2057-64. PubMed ID: 20936622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary biological evaluations of new thalidomide analogues for multiple sclerosis application.
    Contino-Pépin C; Parat A; Périno S; Lenoir C; Vidal M; Galons H; Karlik S; Pucci B
    Bioorg Med Chem Lett; 2009 Feb; 19(3):878-81. PubMed ID: 19103485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE).
    Corrêa JO; Aarestrup BJ; Aarestrup FM
    Exp Neurol; 2010 Nov; 226(1):15-23. PubMed ID: 20406639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis.
    Bolton C
    Inflammopharmacology; 2007 Oct; 15(5):183-7. PubMed ID: 17943249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
    Luccarini I; Ballerini C; Biagioli T; Biamonte F; Bellucci A; Rosi MC; Grossi C; Massacesi L; Casamenti F
    Exp Neurol; 2008 May; 211(1):214-26. PubMed ID: 18346732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Palaszynski KM; Liu H; Loo KK; Voskuhl RR
    J Neuroimmunol; 2004 Apr; 149(1-2):84-9. PubMed ID: 15020068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
    Kanwar JR; Kanwar RK; Krissansen GW
    Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids in the control of neuroinflammation.
    Tischner D; Reichardt HM
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):62-70. PubMed ID: 17555867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM; Gold R; Lühder F
    Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
    Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
    J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.
    Parvaneh Tafreshi A
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):177-81. PubMed ID: 17237570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
    Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
    J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Iranian herbal-marine medicine, MS14, ameliorates experimental allergic encephalomyelitis.
    Tafreshi AP; Ahmadi A; Ghaffarpur M; Mostafavi H; Rezaeizadeh H; Minaie B; Faghihzadeh S; Naseri M
    Phytother Res; 2008 Aug; 22(8):1083-6. PubMed ID: 18570265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L; Zamvil SS
    Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
    Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
    Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.